{{Rsnum
|rsid=7989332
|Gene=CRYL1
|Chromosome=13
|position=20476436
|Orientation=plus
|GMAF=0.2314
|Gene_s=CRYL1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 8.9 | 43.8 | 47.3
| HCB | 4.4 | 32.4 | 63.2
| JPT | 3.6 | 27.7 | 68.8
| YRI | 4.1 | 33.1 | 62.8
| ASW | 3.5 | 22.8 | 73.7
| CHB | 4.4 | 32.4 | 63.2
| CHD | 7.5 | 34.6 | 57.9
| GIH | 9.9 | 25.7 | 64.4
| LWK | 2.8 | 31.2 | 66.1
| MEX | 1.8 | 26.3 | 71.9
| MKK | 2.6 | 19.9 | 77.6
| TSI | 5.9 | 40.2 | 53.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=5E-6
  |OR=2.06
  |ORtxt=[1.507-2.806]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}